Clinical Trials Logo
  1. Home
  2. Osteonecrosis
  3. NCT02893293

Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI — Osteonecro  

Osteonecrosis Clinical Trial

Official title:
Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI

Clinical Trial Summary

The goal of the project is to evaluate osteonecrosis before and after decompression surgery with ferumoxytol-enhanced MRI.

Clinical Trial Description

The goal of the project is to evaluate osteonecrosis before and after decompression surgery with ferumoxytol-enhanced MRI. The investigators approach relies on the FDA-approved iron supplement ferumoxytol (Feraheme), which is used off label as a contrast agent for MRI. Ferumoxytol is composed of iron oxide nanoparticles, which provide a strong T1- and T2-signal on magnetic resonance (MR) images and are taken up by cells in bone marrow. 20 patients will undergo MRI before and after decompression surgery and transplantation of bone marrow derived cells. 10 patients will receive a single intravenous injection of ferumoxytol prior to their surgery. 10 additional patients will serve as untreated controls. The investigators hypothesize that MR images after intravenous injection of ferumoxytol will improve lesion detection and allow to track transplanted bone marrow cells. MR imaging findings will be correlated with clinical outcomes. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02893293
Study type Interventional
Source Stanford University
Contact
Status Enrolling by invitation
Phase Phase 4
Start date May 2015
Completion date December 2023
View Details
See also
  Status Clinical Trial Phase
Terminated NCT04072055 - MOTO Post-marketing Surveillance Study
Terminated NCT02941666 - Human Mesenchymal Stem Cells in the Synovial Fluid of the Hip
Terminated NCT01763684 - Oxford Signature vs. Conventional Global Study N/A
Completed NCT00505219 - Ixmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral Head Phase 3
Withdrawn NCT02632903 - Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study Phase 2
Active, not recruiting NCT01458782 - ACI-C Versus AMIC. A Randomized Trial Comparing Two Methods for Repair of Cartilage Defects in the Knee N/A
Completed NCT01583465 - Efficacy of Aquamantys for Reducing Transfusions With Anterior Supine Intermuscular Approach Total Hip Arthroplasty N/A
Active, not recruiting NCT04401267 - Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma Phase 2
Completed NCT03197623 - Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids Phase 1
Active, not recruiting NCT05283148 - Sickle Cell Disease (SCD) Bone Pain Study N/A
Completed NCT05684588 - Post-COVID-19 Sequelae: Osteonecrosis of Femoral Head N/A
Terminated NCT03269409 - Use of Adipose Derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis Phase 1
Completed NCT00913679 - A Comparison of Two Different Surgical Techniques in Hip Resurfacing Arthroplasty N/A
Completed NCT01345097 - A Short Metaphyseal Fitting Total Hip Arthroplasty in Young and Elderly Patients Phase 4
Recruiting NCT00260897 - Molecular Genetic Study of Avascular Necrosis of the Femoral Head N/A
Not yet recruiting NCT06016634 - Alendronate for Osteonecrosis in Adults With Sickle Cell Disease Phase 2
Completed NCT02077647 - Focused Registry on the Conservative Treatment of Osteoarthritis of the Knee
Recruiting NCT01619124 - Osteonecroses in Pediatric Patients With ALL N/A
Completed NCT02458937 - Functional Outcomes Following Hip Core Decompression in Younger Participants With Osteonecrosis
Recruiting NCT02661139 - Prospective Registry of Prosthodontic Rehabilitation in Oncology Patients Undergoing Jaw Reconstruction